Machine signal
Active cluster buy — 3 distinct insiders, $281.6K, window ends Oct 1, 2026.
Figures computed from official regulatory filings — .
Analysttarget 20 USD (+604%) · consensus 4.5/5 · 2 buy · 0 hold · 0 sell
Ownershipinsiders 11.22% · institutions 7% · short 6.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Beyond Air, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
89 buys62 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Lin Yi-Chien | Buy | $8.1K | conv 56Cluster |
| SEC |
| Lin Yi-Chien | Buy | $5.4K | conv 50Cluster | SEC |
| Lin Yi-Chien | Buy | $43.1K | conv 53Cluster | SEC |
| MOORHEAD DANIEL J | Buy | $25K | conv 100First in 12mo | SEC |
| Goodman Robert Scott | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| Goodman Robert Scott | Buy | $200K | conv 98First in 12mo | SEC |
| Goodman Robert Scott | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| MOORHEAD DANIEL J | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| MOORHEAD DANIEL J | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| MOORHEAD DANIEL J | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gaul Michael A.track record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lee Yoori | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |